Action Potential Duration (APD) Testing on hESC-Derived Cardiomyocytes by ChanTest Corporation

Evaluate compounds in human stem cell-derived, ventricular-type cardiomyocytes. Effects on action potential parameters are evaluated in single human cardiomyocytes using patch-clamp recording Benefits: Human ion channels expressed in a native cardiac environment Detects AP Prolongation (QT risk) and EADs (Torsade trigger) Stable recordings at physiological temperature with minimal diffusion delays Cost-effective Rapid turnaround time


Action Potential Duration (APD) Testing on hESC-Derived Cardiomyocytes by ChanTest Corporation product image
Action Potential Duration (APD) Testing on hESC-Derived Cardiomyocytes

The supplier does not provide quotations for this particular product through SelectScience. You can search for similar products in our product directory.



0 Scientists have reviewed this product


Write the First Review

No Reviews

Evaluate compounds in human stem cell-derived, ventricular-type cardiomyocytes. Effects on action potential parameters are evaluated in single human cardiomyocytes using patch-clamp recording
Benefits:

  • Human ion channels expressed in a native cardiac environment
  • Detects AP Prolongation (QT risk) and EADs (Torsade trigger)
  • Stable recordings at physiological temperature with minimal diffusion delays
  • Cost-effective
  • Rapid turnaround time